Biological and Pharmaceutical Bulletin p. 1076 - 1081 (1997)
Update date:2022-07-29
Topics:
Ohta, Akihiro
Takahashi, Hiromitsu
Miyata, Naoomi
Hirono, Hiroyuki
Nishio, Toyotaka
Uchino, Etsuo
Yamada, Kenji
Aoyagi, Yutaka
Suwabe, Yasushi
Fujitake, Masayuki
Suzuki, Takahiro
Okamoto, Kazuo
This report describes the anti-platelet aggregation activity of 48 pyrazines. Among alkyl- and arylpyrazines tested, 2,3-diphenylpyrazines showed the strongest anti-platelet aggregation activity. Then, various substituents were introduced into the phenyl groups, and the 2,3-bis(p- methoxyphenyl)pyrazine derivatives were consequently found to possess considerably strong inhibitory activity.
View Morewebsite:https://www.bocsci.com/
Contact:1-631-485-4226
Address:Ramsey Road
Shanghai birch chemical technology co.,ltd
Contact:+86-21-54096810
Address:No.2588,Jungong Road,Shanghai,China
Hangzhou Pharma & Chem Co.,Ltd.
Contact:+86-571-87040515
Address:No,139Qingchun Rd
Ningbo Hi-tech Zone Nice-Synth Chemical Industry Ltd.
Contact:+86-(574)-81110986
Address:No. 1210, Building 3, Wante Business Centre, Hi-tech Zone, Ningbo
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Doi:10.1055/s-2008-1077824
(2008)Doi:10.1055/s-2005-868514
(2005)Doi:10.1039/c8ob01868e
(2018)Doi:10.1016/S0040-4039(00)60871-7
(1992)Doi:10.1016/j.saa.2011.03.022
(2011)Doi:10.1021/jo01129a015
(1953)
